Systemic and Topical Antibiotics
Antibiotics, both topical and oral, are a cornerstone of everyday dermatology. They clear the surface bacteria behind many skin conditions (Cutibacterium acnes, Staphylococcus aureus, Streptococcus pyogenes) and help control acute and chronic inflammation. Notably, many dermatologic antibiotics, particularly the tetracyclines and macrolides, also have anti-inflammatory effects that are independent of their antibacterial action. At the same time, antimicrobial resistance (AMR), driven largely by prolonged or stand-alone use of topical antibiotics, has become a serious challenge.
At Haute-Derma, we prescribe antibiotics according to strict antibiotic stewardship principles: we choose the most effective combinations, limit treatment duration, and add light-based therapy or chemical peels wherever possible to reduce the risk of resistant bacteria.
How Antibiotics Work: Mechanisms and Pharmacodynamics
Direct Antibacterial Effects
Antibiotics disrupt processes that bacteria need to survive:
- Inhibiting bacterial protein synthesis (30S and 50S ribosomal subunits): Tetracyclines (doxycycline, lymecycline) bind reversibly to the 30S subunit, while macrolides (erythromycin, azithromycin) and lincosamides (clindamycin) bind to the 50S subunit. This blocks peptide chain elongation, weakening C. acnes and staphylococci and holding back their growth.
- Inhibiting cell wall and membrane synthesis: Beta-lactams (cephalexin, amoxicillin-clavulanate) inhibit transpeptidase enzymes, preventing peptidoglycan synthesis so the bacteria break apart. Mupirocin, which does not act on the cell wall, instead inhibits the enzyme isoleucyl-tRNA synthetase, shutting down protein synthesis in S. aureus.
- Disrupting DNA/RNA: Metronidazole and quinolones (nadifloxacin) damage bacterial DNA, acting against anaerobes and against Gram-negative and Gram-positive organisms.
Independent Anti-inflammatory Effects
Beyond suppressing bacteria, tetracyclines and macrolides have strong anti-inflammatory effects through several mechanisms:
- Inhibiting matrix metalloproteinases (MMPs): This limits breakdown of collagen and the extracellular matrix around the follicular opening.
- Reducing pro-inflammatory cytokines: They suppress production of IL-1β, TNF-α, IL-8 and IL-12 by monocytes and keratinocytes.
- Inhibiting neutrophil chemotaxis: This reduces pus formation, redness, swelling and deep cyst formation in severe acne and pyoderma.
Classes of Antibiotics Used in Dermatology
Topical Antibiotics
Used for localized, superficial inflammatory lesions or skin infections that cover a small area.
- Acne: clindamycin 1%, erythromycin 2–4%, nadifloxacin 1%.
- Skin infections (impetigo, boils, folliculitis): mupirocin 2%, fusidic acid 2%.
- Rosacea / perioral dermatitis: metronidazole 0.75–1%.
Oral (Systemic) Antibiotics
Used for moderate to severe inflammatory acne, cellulitis, widespread impetigo, or deep skin infections.
- Tetracyclines (first choice for acne and rosacea): doxycycline (50–100 mg/day), lymecycline (300–600 mg/day).
- Macrolides (alternative for patients with allergies or during pregnancy): azithromycin (500 mg/day, 3 days a week), erythromycin.
- Beta-lactams (staphylococcal and streptococcal skin infections): cephalexin (500 mg 2–3 times daily), amoxicillin-clavulanate.
Comparing Common Antibiotics in Dermatology
| Drug (Generic) | Main Mechanism of Action | Preferred Indications |
|---|---|---|
| Doxycycline | Binds the 30S subunit + anti-inflammatory (MMP inhibition) | Inflammatory acne, rosacea, folliculitis |
| Clindamycin | Binds the 50S subunit, reduces C. acnes | Pustular acne, mild nodular acne |
| Fusidic acid | Inhibits bacterial elongation factor G (EF-G) | Impetigo, paronychia, boils |
| Mupirocin | Inhibits isoleucyl-tRNA synthetase | Impetigo, pyoderma, eradication of resistant S. aureus |
| Cephalexin | Inhibits peptidoglycan cell wall synthesis | Cellulitis, large boils, widespread impetigo |
Antibiotic Stewardship and Treatment Protocol at Haute-Derma
Never Use a Topical Antibiotic on Its Own
- Always combine: A topical antibiotic (clindamycin) should always be paired with benzoyl peroxide (BPO 2.5–5%) or a topical retinoid (adapalene/tretinoin). Benzoyl peroxide releases reactive oxygen that kills C. acnes by oxidation; bacteria do not become resistant to it, and it markedly reduces the emergence of antibiotic-resistant strains.
Limit Treatment Duration
- Topical antibiotics: No longer than 8–12 weeks.
- Oral antibiotics: Peak benefit is reached within 8–12 weeks (16 weeks at most). Once inflammatory lesions have dropped by 70–80%, we step down: the oral antibiotic is stopped and maintenance continues with a topical retinoid plus BPO.
How to Take Oral Antibiotics Correctly
- Doxycycline: take it with a full glass of water (at least 200 ml) while standing or sitting, and do not lie down for 30 minutes afterward to avoid esophageal ulceration. Do not take it together with milk, antacids, or iron or calcium supplements (keep at least 2 hours apart), because they form insoluble chelates that stop the drug from working.
Technology-Based Alternatives to Antibiotics
- Bio-Light (415 nm blue light): Activates the endogenous porphyrins of C. acnes, generating free radicals that kill the bacteria without inducing resistance.
- Chemical peels (salicylic acid / mandelic acid): Unclog follicles, provide a mild antibacterial effect and penetrate sebum, lowering the natural bacterial load on the skin.